Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs... Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and better safety as a result of fewer off-target effects. Its lead PDC therapeutic, iopofosine is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells. Show more
Oral Presentation Presented at ASH 2024 Showed Iopofosine I 131 Achieved an 83.6% ORR and Exceeded Primary and Secondary Efficacy Endpoints in Phase 2 CLOVER-WaM Study for Relapsed/Refractory...
Evaluating strategic options for iopofosine I 131 a late-stage clinical program with compelling Phase 2 data and a substantial market opportunity Focusing on advancing radiotherapeutic assets...
Phase 2 CLOVER-WaM pivotal study data selected for oral presentation at 66th Annual American Society of Hematology Meeting and Exposition Raised approximately $19.4 million with potential to...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0075 | -2.77777777778 | 0.27 | 0.2719 | 0.2325 | 781169 | 0.25147798 | CS |
4 | -0.0869 | -24.8712077848 | 0.3494 | 0.3597 | 0.22975 | 2542036 | 0.27178591 | CS |
12 | -1.8675 | -87.676056338 | 2.13 | 2.18 | 0.224 | 2811975 | 0.38947678 | CS |
26 | -1.5875 | -85.8108108108 | 1.85 | 2.29 | 0.224 | 1371566 | 0.56877707 | CS |
52 | -3.4375 | -92.9054054054 | 3.7 | 4.45 | 0.224 | 1092927 | 1.58628186 | CS |
156 | -0.3074 | -53.9392875943 | 0.5699 | 6.7568 | 0.224 | 572154 | 1.97264579 | CS |
260 | -2.5075 | -90.523465704 | 2.77 | 6.7568 | 0.224 | 696956 | 1.80722072 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales